You are here: About the OfficeInternational cooperationInternational organisationsInternational research infrastructuresEuropean Research Infrastructure for Imaging Technologies in Biological and Medical Sciences (EuBI-ERIC)
European Research Infrastructure for Imaging Technologies in Biological and Medical Sciences (EuBI-ERIC)
26 April 2021
Last modified: 26 April 2021
Reading time: 2 minute(s)

EuBI-ERICProvides open physical access to a wide range of world-class biological and biomedical imaging technologies for researchers in life sciences.

It aims to organize a network of microscopic and medical imaging laboratory services, and make costly and expertise-intensive methods available in Europe.

Short name EuBI-ERIC
Name The European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences 
Official website http://www.eurobioimaging.eu/
Year of foundation 2010 (operational phase: from 2019)
ESFRI project/landmark landmark
Headquarters Heidelberg, Germany
Number of member countries 14
Participating countries Members: Austria, Bulgaria, Czech Republic, Denmark, Finland, France, Hungary, Israel, Italy, Netherlands, Norway, Portugal, Sweden, UK, + European Molecular & Biology Laboratory (EMBL) Observers: Belgium

Hungary’s accession 2016
Partner institutions in Hungary University of Debrecen
Biological Research Centre, Szeged, Semmelweis University,
Femtonics Kft.
University of Pécs, Szentágothai Research Centre
Public administration representative Klára Horváth
National Research, Development and Innovation Office
Department of International Affairs
1077 Budapest, Kéthly Anna tér 1.
Phone: +36 1 896 3748
Email: klara.horvath@nkfih.gov.hu
Professional representative János Szöllősi
professor, academician
University of Debrecen, ÁOK, Department of Biophysics and Cell Biology

György Vámosi
senior research fellow
University of Debrecen, ÁOK, Department of Biophysics and Cell Biology
Membership payments 2015: -
2016: -
2017: EUR 0
2018: EUR 0
2019: EUR 0
2020: EUR 21,627.21 (≈ HUF 7.8 million)

Benefits of the membership for Hungary

  • Research results increase our understanding of various diseases, from diagnosis to treatment, improving the general health of the population.
  • Gives access for the Hungarian research community to laboratories equipped with the most advanced technologies.
  • The portfolio of services provided to pharmaceutical development and biotech companies is extended with new bioimaging technologies introduced based on the experience gained in foreign “Node” status institutions, which increases the R&D performance and the efficiency of companies.
  • From 2018, Hungary connects to the international infrastructure through the Cellular Imaging Hungary consortium, which comprises several Hungarian “Node” status institutions.
Updated: 26 April 2021
Feedback
Was this page helpful?